Northwestern Mutual Wealth Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
ACA
DCM
JT
Northwestern Mutual Wealth Management's DFTX Position: Q2 2026 in Review
Northwestern Mutual Wealth Management reduced its Definium Therapeutics (DFTX) stake by 8.4% in Q2 2026, selling an estimated $321 and leaving 142 shares worth $6.68K. The position accounts for ﹤0.01% of the portfolio, ranked #3268.
Northwestern Mutual Wealth Management first reported a position in DFTX in Q3 2021 and has held it in 17 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.
- Northwestern Mutual Wealth Management held 142 shares of Definium Therapeutics worth $6.68K as of Q2 2026.
- Northwestern Mutual Wealth Management sold 13 Definium Therapeutics shares in Q2 2026, an estimated $321.
- Definium Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3268 holding.
- Northwestern Mutual Wealth Management first reported a position in Definium Therapeutics in Q3 2021 and has held it in 17 quarters since.
- 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.